Physician profile
Lora E Greene
NPI 1447546544
$2,214.75
in general payments reported to CMS, 2019-2025
24 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $123 · 2021: $444 · 2022: $551 · 2023: $465 · 2024: $271 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.27 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $370.94 | 2021-2025 | |
| Exeltis, USA INC. | $354.59 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $148.15 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $136.74 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $108.02 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $49.72 | 2019-2023 | Fluent Fluid Management System |
| Avion Pharmaceuticals | $45.19 | 2019-2022 | |
| Amgen INC. | $43.18 | 2019-2020 | |
| Millicent US INC | $39.22 | 2025 | Intrarosa, Femlyv |
| Pfizer INC. | $36.45 | 2024-2025 | |
| Davol INC. | $36.26 | 2020 | |
| Baxter Healthcare | $30.82 | 2025 | Perclot |
| Agile Therapeutics, INC. | $30.25 | 2022 | |
| Mylan Pharmaceuticals INC. | $22.97 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $19.74 | 2024 | |
| Smith+Nephew, INC. | $16.27 | 2025 | Pico |
| Shield Therapeutics INC | $15.66 | 2024 | |
| Sage Therapeutics, LLC | $15.48 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.63 | 2019 | |
| Evofem Biosciences, INC. | $13.55 | 2020 | |
| Conmed Corporation | $12.71 | 2021 | |
| Duchesnay USA Incorporated | $12.66 | 2019 | |
| Allergan, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.